Stock Comparison
GILD vs JNJ
Gilead Sciences Inc and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$158.77B
$613.02B
P/E (TTM)
17.4
29.5
Forward P/E
15.2
22.0
Price/Sales
5.3
6.4
Price/Book
6.8
7.6
EV/EBITDA
12.0
19.2
Dividend Yield
2.58%
2.12%
Profitability
Net Margin
31.00%
21.80%
Operating Margin
39.30%
27.40%
Return on Equity
43.40%
26.40%
Return on Assets
13.30%
8.42%
Growth (YoY)
Revenue Growth
4.40%
9.90%
Earnings Growth
54.80%
-52.90%
Price & Risk
Beta
0.3
0.3
52-Week High
$155.38
$255.11
52-Week Low
$105.01
$147.81
Analyst Target
$157.57
$257.32
Compare GILD and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.